Provider

Executives say they’re underprepared for challenges ranging from AI to cost containment.

The company said the acquisition allows it to begin delivering a comprehensive stepped care model that incorporates group therapy and peer support.

The company closed after failing to secure additional investment due to regulatory uncertainty and delayed action on extending the Acute Hospital Care at Home Waiver Program.

Jennifer Goldsack, CEO of the Digital Medicine Society, outlines DiMe's new project focused on aging-in-place with healthcare technologies and reimbursing remote patient monitoring as federal and private insurers' coverage policies evolve.

Dr. Ronald Whelan, CEO of South Africa's Discovery Health, discusses how the insurer uses a shared-value model supported by wearables, data and rewards to incentivize healthier habits.

ACCESS is a decade-long initiative to expand tech-enabled care and outcome-based payments for Medicare patients with obesity, diabetes, chronic pain and depression.

Ciba Health collaborates with Canadian health benefits administrator Quikcard, and Octave Bioscience signs a partnership agreement with Quest Diagnostics.

OSF HealthCare's Brandi Clark says that, in 2026, insurers' payments for telemedicine and remote patient monitoring reimbursement will increasingly align with organizations’ value-based care maturity.

The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.

For now, the Trump Administration is turning its focus to The Genesis Mission, a new federal artificial intelligence effort that it says is "comparable in urgency and ambition to the Manhattan Project."